ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,932 | -17.4% | 11,557 | 0.0% | 0.00% | – |
| Q1 2023 | $7,180 | -4.3% | 11,557 | 0.0% | 0.00% | – |
| Q4 2022 | $7,501 | -62.5% | 11,557 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $20,000 | 0.0% | 11,557 | -62.0% | 0.00% | 0.0% |
| Q1 2022 | $20,000 | -39.4% | 30,402 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $33,000 | -46.8% | 30,402 | -0.5% | 0.00% | -50.0% |
| Q3 2021 | $62,000 | -29.5% | 30,568 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $88,000 | +6.0% | 30,568 | +33.8% | 0.00% | 0.0% |
| Q1 2021 | $83,000 | -42.4% | 22,852 | -1.1% | 0.00% | -87.5% |
| Q3 2017 | $144,000 | +77.8% | 23,099 | +78.8% | 0.02% | +60.0% |
| Q2 2017 | $81,000 | +2.5% | 12,922 | -7.5% | 0.02% | 0.0% |
| Q3 2016 | $79,000 | +426.7% | 13,966 | +365.5% | 0.02% | – |
| Q4 2014 | $15,000 | -99.9% | 3,000 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $12,090,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,642,959 | $25,186,000 | 3.76% |
| MSD Partners, L.P. | 15,151,516 | $26,061,000 | 2.11% |
| MSD Partners, L.P. | 7,575,758 | $13,030,000 | 1.05% |
| MAGNOLIA CAPITAL ADVISORS LLC | 418,569 | $720,000 | 0.61% |
| STEEL GROVE CAPITAL ADVISORS, LLC | 1,080,000 | $1,858,000 | 0.33% |
| EAM Investors, LLC | 454,625 | $782,000 | 0.17% |
| Allred Capital Management, LLC | 158,000 | $271,000 | 0.17% |
| Boxer Capital, LLC | 1,500,000 | $2,580,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 608,037 | $1,046,000 | 0.14% |
| CHIRON CAPITAL MANAGEMENT, LLC | 116,860 | $201,000 | 0.14% |